Coverys, a Boston-based provider of medical professional liability insurance and related services, announced the creation of Coverys Specialty Insurance Company, a new excess and surplus lines underwriting company.
The New Jersey-domiciled Coverys Specialty’s offering will round out Coverys’ suite of products and services by providing tailored excess and surplus coverage for unique or hard to place risks, according to the announcement. Coverys Specialty policies will be accessible through select agents and brokers.
“Establishing Coverys Specialty further demonstrates our commitment to expanding our services in the large account underwriting arena,” said Gregg L. Hanson, CEO and president of Coverys.
Coverys Specialty will provide customers with flexible speed to market insurance coverage that addresses emerging healthcare delivery exposures and trends, Coverys said. The company also said Coverys Specialty will provide coverage for healthcare facilities with unique risk profiles that seek insurance services typically not available in traditional insurance market.
Coverys Specialty will be operated under the leadership of Sam Mezzich, president, and Edward Lyons, senior vice president. Both come from Arch Insurance.
In this new role, Mezzich will lead Coverys Specialty and direct all E&S underwriting efforts. Mezzich joins Coverys with over 25 years of medical professional underwriting experience, most recently at Arch Insurance where he served as a regional vice president for 12 years from the company’s inception. Prior to his time at Arch, he held both managerial and underwriting positions at GE Capital/ERC, CNA, AIG, and MLMIC.
As senior vice president, Lyons will work closely with Mezzich to launch Coverys Specialty. Lyons previously spent 12 years at Arch Insurance, where he served as the assistant vice president of underwriting in the healthcare facilities and programs area. Prior to Arch, he held multiple underwriting positions at St. Paul Cos., including underwriting director for the physicians and surgeons product.
Was this article valuable?
Here are more articles you may enjoy.